Le traitement des fistules anales dans la maladie de Crohn = Treatment of anal fistula in Crohn's diseaseDEWIT, O.Acta endoscopica. 2007, Vol 37, Num 3, pp 285-294, issn 0240-642X, 10 p.Article

L'azathioprine dans la maladie de Crohn: un traitement toujours d'actualité = Azathioprine in the treatment of Crohn enteritis : always the same interestBEIAICHE, Jacques; LOUIS, Edouard.Hépato-gastro (Montrouge). 2001, Vol 8, Num 3, pp 207-213, issn 1253-7020Article

BREVET 2.175.316 (B) (7208253). A 9 MARS 1972. DISPOSITIF D'INJECTION POUR BRULEUR A COMBUSTIBLE LIQUIDEsdPatent

Predictors of severe Crohn's diseaseLOLY, Catherine; BELAICHE, Jacques; LOUIS, Edouard et al.Scandinavian journal of gastroenterology. 2008, Vol 43, Num 8, pp 948-954, issn 0036-5521, 7 p.Article

Genetics of ulcerative colitis: the come-back of interleukin 10LOUIS, Edouard; LIBLOULLE, Cecile; REENAERS, Catherine et al.Gut. 2009, Vol 58, Num 9, pp 1173-1176, issn 0017-5749, 4 p.Article

Contribution de la protéomique au diagnostic des cancers colorectaux = Contribution of proteomics to colorectal cancer diagnosisMEUWIS, Marie-Alice; LOUIS, E; MERVILLE, Marie-Paule et al.Acta endoscopica. 2007, Vol 37, Num 3, pp 295-303, issn 0240-642X, 9 p.Article

L'infliximab dans le traitement prolongé de la maladie de Crohn non fistulisante = Long term treatment with infliximab in non-fistulising Crohn's diseaseVERMEIRE, Séverine; VAN ASSCHE, G; RUTGEERTS, P et al.Acta endoscopica. 2007, Vol 37, Num 3, pp 271-283, issn 0240-642X, 13 p.Article

Dépistage du cancer colorectal en 2006 = Screening for colorectal cancer in 2006PIRONT, Patricia; LOUIS, E; BELAICHE, J et al.Acta endoscopica. 2007, Vol 37, Num 3, pp 305-313, issn 0240-642X, 9 p.Article

La gestion des déchets Un peu de technique, beaucoup d'économie..YELKOUNI, Martin; POUGET, Louis-Edouard; MAHAMADOU CISSE, Sidi et al.Liaison énergie francophonie. 2011, Num 90, pp 18-25, issn 0840-7827, 8 p.Article

Rheumatoid arthritis and pregnancy: evolution of disease activity and pathophysiological considerations for drug useHAZES, Johanna M. W; COULIE, Pierre G; GEENEN, Vincent et al.Rheumatology (Oxford. Print). 2011, Vol 50, Num 11, pp 1955-1968, issn 1462-0324, 14 p.Article

Hémorragies digestives hautes aiguës : Expérience d'un milieu rural = Acute upper digestive bleeding : experience of a farming environmentDIARRA, M; SOUCKO-DIARRA, A; DOLO, M et al.Acta endoscopica. 2007, Vol 37, Num 3, pp 321-326, issn 0240-642X, 6 p.Article

Development of the Paris Definition of Early Crohn's Disease for Disease-Modification Trials: Results of an International Expert Opinion ProcessPEYRIN-BIROULET, Laurent; BILLIOUD, Vincent; HIGGINS, Peter D. R et al.The American journal of gastroenterology. 2012, Vol 107, Num 12, pp 1770-1776, issn 0002-9270, 7 p.Article

Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47ANDERSON, Carl A; BOUCHER, Gabrielle; LAGACE, Caroline et al.Nature genetics. 2011, Vol 43, Num 3, pp 246-252, issn 1061-4036, 7 p.Article

Common variants in the NLRP3 region contribute to Crohn's disease susceptibilityVILLANI, Mexandra-Chloé; LEMIRE, Mathieu; GAUDET, Daniel et al.Nature genetics. 2009, Vol 41, Num 1, pp 71-76, issn 1061-4036, 6 p.Article

The TNF/ADAM 17 system : implication of an ADAM 17 haplotype in the clinical response to infliximab in Crohn's diseaseDIDEBERG, Vinciane; THEATRE, Emilie; BOURS, Vincent et al.Pharmacogenetics and genomics (Print). 2006, Vol 16, Num 10, pp 727-734, issn 1744-6872, 8 p.Article

Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's diseaseBARRETT, Jeffrey C; HANSOUL, Sarah; BITTON, Alain et al.Nature genetics. 2008, Vol 40, Num 8, pp 955-962, issn 1061-4036, 8 p.Article

Monomeric Calgranulins Measured by SELDI-TOF Mass Spectrometry and Calprotectin Measured by ELISA as Biomarkers in ArthritisDE SENY, Dominique; FILLET, Marianne; MALAISE, Michel et al.Clinical chemistry (Baltimore, Md.). 2008, Vol 54, Num 6, pp 1066-1075, issn 0009-9147, 10 p.Article

Immunogenicity of infliximab : how to handle the problem ?BAERT, Filip; DE VOS, Martine; LOUIS, Edouard et al.Acta gastro-enterologica belgica (English ed.). 2007, Vol 70, Num 2, pp 163-170, issn 1784-3227, 8 p.Article

No association between C-reactive protein gene polymorphisms and decrease of C-reactive protein serum concentration after infliximab treatment in Crohn's diseaseWILLOT, Stéphanie; VERMEIRE, Severine; WATIER, Hervé et al.Pharmacogenetics and genomics (Print). 2006, Vol 16, Num 1, pp 37-42, issn 1744-6872, 6 p.Article

Epidemiology of inflammatory bowel diseases in the elderly in the province of Liège: A three-year prospective study : Tube digestif et pancréas = Digestive tract and pancreasPIRONT, Patricia; LOUIS, Edouard; LA TOUR, Pascale et al.Gastroentérologie clinique et biologique. 2002, Vol 26, Num 2, pp 157-161, issn 0399-8320Article

Clinical and genetic factors associated with sacroiliitis in Crohn's diseasePEETERS, Harald; VANDER CRUYSSEN, Bert; MIELANTS, Herman et al.Journal of gastroenterology and hepatology. 2008, Vol 23, Num 1, pp 132-137, issn 0815-9319, 6 p.Article

An insertion-deletion polymorphism in the Interferon Regulatory Factor 5 (IRF5) gene confers risk of inflammatory bowel diseasesDIDEBERG, Vinciane; KRISTJANSDOTTIR, Gudlaug; FRANCHIMONT, Denis et al.Human molecular genetics (Print). 2007, Vol 16, Num 24, pp 3008-3016, issn 0964-6906, 9 p.Article

Demographic and clinical parameters influencing the short-term outcome of anti-tumor necrosis factor (infliximab) treatment in Crohn's diseaseVERMEIRE, Severine; LOUIS, Edouard; PELCKMANS, Paul et al.The American journal of gastroenterology. 2002, Vol 97, Num 9, pp 2357-2363, issn 0002-9270Article

Discovery and biochemical characterisation of four novel biomarkers for osteoarthritisDE SENY, Dominique; SHARIF, Mohammed; KIRWAN, John et al.Annals of the rheumatic diseases. 2011, Vol 70, Num 6, pp 1144-1152, issn 0003-4967, 9 p.Article

Page / 2